These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10455963)

  • 1. Increased bile duct complications and/or chronic rejection in crossmatch positive human liver allografts.
    Takaya S; Jain A; Yagihashi A; Nakamura K; Kobayashi M; Takeuchi K; Suzuki S; Iwaki Y; Demetris AJ; Todo S; Fung JJ; Starzl TE
    Transplant Proc; 1999 Aug; 31(5):2028-31. PubMed ID: 10455963
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased bile duct complications in liver transplantation across the ABO barrier.
    Sanchez-Urdazpal L; Batts KP; Gores GJ; Moore SB; Sterioff S; Wiesner RH; Krom RA
    Ann Surg; 1993 Aug; 218(2):152-8. PubMed ID: 8342994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vanishing bile-duct syndrome following liver transplantation--is it reversible?
    Hubscher SG; Buckels JA; Elias E; McMaster P; Neuberger J
    Transplantation; 1991 May; 51(5):1004-10. PubMed ID: 1851580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.
    Musat AI; Agni RM; Wai PY; Pirsch JD; Lorentzen DF; Powell A; Leverson GE; Bellingham JM; Fernandez LA; Foley DP; Mezrich JD; D'Alessandro AM; Lucey MR
    Am J Transplant; 2011 Mar; 11(3):500-10. PubMed ID: 21342448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex mismatch as a risk factor for chronic rejection of liver allografts.
    Candinas D; Gunson BK; Nightingale P; Hubscher S; McMaster P; Neuberger JM
    Lancet; 1995 Oct; 346(8983):1117-21. PubMed ID: 7475600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antibody crossmatch in liver transplantation.
    Gordon RD; Fung JJ; Markus B; Fox I; Iwatsuki S; Esquivel CO; Tzakis A; Todo S; Starzl TE
    Surgery; 1986 Oct; 100(4):705-15. PubMed ID: 3532391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of C4d staining in ABO-identical/compatible liver transplantation.
    Sakashita H; Haga H; Ashihara E; Wen MC; Tsuji H; Miyagawa-Hayashino A; Egawa H; Takada Y; Maekawa T; Uemoto S; Manabe T
    Mod Pathol; 2007 Jun; 20(6):676-84. PubMed ID: 17431411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late mortality and morbidity after liver transplantation.
    Iwatsuki S; Starzl TE; Gordon RD; Esquivel CO; Todo S; Tzakis AG; Makowka L; Marsh JW; Miller CM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2373-7. PubMed ID: 3547930
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of positive lymphocyte crossmatch and HLA mismatching on vanishing bile duct syndrome in human liver allografts.
    Batts KP; Moore SB; Perkins JD; Wiesner RH; Grambsch PM; Krom RA
    Transplantation; 1988 Feb; 45(2):376-9. PubMed ID: 3278430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High one-month liver graft failure rates in flow cytometry crossmatch-positive recipients.
    Ogura K; Terasaki PI; Koyama H; Chia J; Imagawa DK; Busuttil RW
    Clin Transplant; 1994 Apr; 8(2 Pt 1):111-5. PubMed ID: 8019019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive lymphocytotoxic crossmatch does not adversely affect survival in living donor liver transplantation.
    Sugawara Y; Tamura S; Kaneko J; Togashi J; Makuuchi M; Kokudo N
    Dig Surg; 2009 Feb; 26(6):482-6. PubMed ID: 20068321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute vanishing bile duct syndrome after interferon therapy for recurrent HCV infection in liver-transplant recipients.
    Dousset B; Conti F; Houssin D; Calmus Y
    N Engl J Med; 1994 Apr; 330(16):1160-1. PubMed ID: 8133870
    [No Abstract]   [Full Text] [Related]  

  • 13. Pathogenesis and treatment of bile duct loss after liver transplantation.
    Inomata Y; Tanaka K
    J Hepatobiliary Pancreat Surg; 2001; 8(4):316-22. PubMed ID: 11521176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of a positive T-lymphocytotoxic crossmatch on hepatic allograft survival and rejection.
    Bathgate AJ; McColl M; Garden OJ; Forsythe JL; Madhavan KK; Hayes PC
    Liver Transpl Surg; 1998 Jul; 4(4):280-4. PubMed ID: 9649641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation.
    O'Grady JG; Alexander GJ; Sutherland S; Donaldson PT; Harvey F; Portmann B; Calne RY; Williams R
    Lancet; 1988 Aug; 2(8606):302-5. PubMed ID: 2899720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orthotopic liver transplantation (OLT): Contribution of imaging and interventional radiology in preparing the transplantation and managing complications. Part 2: Post-OLT complications and their treatment.
    Golfieri R; Giampalma E; Fusco F; Grazi G; Ercolani G; Sama C; Morelli C; Bolondi L; Trevisani F; Mazzella G; Ballardini G; Pinna AD
    Radiol Med; 2005; 110(5-6):433-81; quiz 482-3. PubMed ID: 16437033
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute liver allograft rejection--is treatment always necessary?
    Dousset B; Hubscher SG; Padbury RT; Gunson BK; Buckels JA; Mayer AD; Elias E; McMaster P; Neuberger JM
    Transplantation; 1993 Mar; 55(3):529-34. PubMed ID: 8456473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of color Doppler ultrasonography in monitoring normal orthotopic liver transplantation and postoperative complications.
    Huang DZ; Le GR; Zhang QP; Li KY; Ye QF; Zhu W; Chen YC
    Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):54-8. PubMed ID: 14599930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed granuloma formation in a patient with vanishing bile duct syndrome 7 years post-liver transplantation.
    Anania FA; Howell CD; Laurin JM; Drachenberg CI
    Liver Transpl; 2001 Nov; 7(11):999-1001. PubMed ID: 11699038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy.
    Takaya S; Duquesnoy R; Iwaki Y; Demetris J; Yagihashi A; Bronsther O; Iwatsuki S; Starzl TE
    Transplant Proc; 1991 Feb; 23(1 Pt 1):396-9. PubMed ID: 1703691
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.